:

Yibo He1, Qianran Hong1, Shiliang Chen1

  • 1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.

PubMed
概括

针对胃癌 (GC) 中的瘤相关巨细胞 (TAM) 显示出改善患者结果的希望. 战略重点是将免疫抑制M2 TAM重编程为抗瘤M1表型,增强癌症疗法.